Enhancers are cis-acting elements that control the transcription of target genes and are transcribed into a class of noncoding RNAs (ncRNAs) termed enhancer RNAs (eRNAs). eRNAs have shorter half-lives than mRNAs and long noncoding RNAs; however, the frequency of transcription of eRNAs is close to that of mRNAs. eRNA expression is associated with a high level of histone mark H3K27ac and a low level of H3K27me3. Although eRNAs only account for a small proportion of ncRNAs, their functions are important. eRNAs can not only increase enhancer activity by promoting the formation of enhancer-promoter loops but also regulate transcriptional activation. Increasing numbers of studies have found that eRNAs play an important role in the occurrence and development of brain diseases; however, further research into eRNAs is required. This review discusses the concept, characteristics, classification, function, and potential roles of eRNAs in brain diseases.
AchourMLe GrasSKeimeCParmentierFLejeuneFXBoutillierAL, and others. 2015. Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington’s disease mice. Hum Mol Genet24(12):3481–96.
2.
AdhikarySRoySChaconJGadadSSDasC.2021. Implications of enhancer transcription and eRNAs in cancer. Cancer Res81(16):4174–82.
3.
Alvarez-DominguezJRHuWYuanBShiJParkSSGromatzkyAA, and others. 2014. Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. Blood123(4):570–81.
4.
Alvarez-DominguezJRKnollMGromatzkyAALodishHF. 2017. The super-enhancer-derived alncRNA-EC7/Bloodlinc potentiates red blood cell development in trans. Cell Rep19(12):2503–14.
5.
AnneyRKleiLPintoDAlmeidaJBacchelliEBairdG, and others. 2012. Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum Mol Genet21(21):4781–92.
6.
AnneyRKleiLPintoDReganRConroyJMagalhaesTR, and others. 2010. A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet19(20):4072–82.
7.
ArnerEDaubCOVitting-SeerupKAnderssonRLiljeBDrabløsF, and others. 2015. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science347(6225):1010–4.
8.
AustenaaLMBarozziISimonattoMMasellaSDella ChiaraGGhislettiS, and others. 2015. Transcription of mammalian cis-regulatory elements is restrained by actively enforced early termination. Mol Cell60(3):460–74.
9.
BhattaraiSAkellaAGandhiADharapA.2021. Modulation of brain pathology by enhancer RNAs in cerebral ischemia. Mol Neurobiol58(4):1482–90.
10.
BhattaraiSPontarelliFPrendergastEDharapA.2017. Discovery of novel stroke-responsive lncRNAs in the mouse cortex using genome-wide RNA-seq. Neurobiol Dis108:204–12.
BoyleAPDavisSShulhaHPMeltzerPMarguliesEHWengZ, and others. 2008. High-resolution mapping and characterization of open chromatin across the genome. Cell132(2):311–22.
13.
CarulloNVNPhillips IiiRASimonRCSotoSARHindsJESalisburyAJ, and others. 2020. Enhancer RNAs predict enhancer-gene regulatory links and are critical for enhancer function in neuronal systems. Nucleic Acids Res48(17):9550–70.
14.
ChangHCaiXLiHJLiuWPZhaoLJZhangCY, and others. 2021. Functional genomics identify a regulatory risk variation rs4420550 in the 16p11.2 schizophrenia-associated locus. Biol Psychiatry89(3):246–55.
15.
ChenHLiangH.2020. A high-resolution map of human enhancer RNA loci characterizes super-enhancer activities in cancer. Cancer Cell38(5):701–715.e5.
16.
CoreLJMartinsALDankoCGWatersCTSiepelALisJT. 2014. Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers. Nat Genet46(12):1311–20.
17.
De SantaFBarozziIMiettonFGhislettiSPollettiSTusiBK, and others. 2010. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol8(5):e1000384.
18.
DingMLiuYLiaoXZhanHLiuYHuangW.2018. Enhancer RNAs (eRNAs): new insights into gene transcription and disease treatment. J Cancer9(13):2334–40.
19.
DjebaliSDavisCAMerkelADobinALassmannTMortazaviA, and others. 2012. Landscape of transcription in human cells. Nature489(7414):101–8.
20.
DongXLiaoZGritschDHadzhievYBaiYLocascioJJ, and others. 2018. Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease. Nat Neurosci21(10):1482–92.
21.
Dykstra-AielloCJicklingGCAnderBPShroffNZhanXLiuD, and others. 2016. Altered expression of long noncoding RNAs in blood after ischemic stroke and proximity to putative stroke risk loci. Stroke47(12):2896–903.
22.
FangBGuanDLazarMA. 2021. Using GRO-Seq to measure circadian transcription and discover circadian enhancers. Methods Mol Biol2130:127–48.
23.
FangKHuangWSunYMChenTQZengZCYangQQ, and others. 2020. Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression. Genome Biol21(1):269.
24.
FromerMRoussosPSiebertsSKJohnsonJSKavanaghDHPerumalTM, and others. 2016. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci19(11):1442–53.
25.
GilNUlitskyI.2018. Production of spliced long noncoding RNAs specifies regions with increased enhancer activity. Cell Syst7(5):537–547.e3.
26.
GrossCChangCWKellySMBhattacharyaAMcBrideSMDanielsonSW, and others. 2015. Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome. Cell Rep11(5):727–36.
27.
GuoXYZhongSWangZNXieTDuanHZhangJY, and others. 2021. Immunogenomic profiling demonstrate AC003092.1 as an immune-related eRNA in glioblastoma multiforme. Front Genet12:633812.
28.
GurumurthyAYuDTSteesJRChamalesPGavrilovaEWasselP, and others. 2021. Super-enhancer mediated regulation of adult beta-globin gene expression: the role of eRNA and Integrator. Nucleic Acids Res49(3):1383–96.
29.
GuttmanMRinnJL. 2012. Modular regulatory principles of large non-coding RNAs. Nature482(7385):339–46.
30.
HahNMurakamiSNagariADankoCGKrausWL. 2013. Enhancer transcripts mark active estrogen receptor binding sites. Genome Res23(8):1210–23.
31.
HarismendyONotaniDSongXRahimNGTanasaBHeintzmanN, and others. 2011. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response. Nature470(7333):264–8.
32.
HaubergMEFullardJFZhuLCohainATGiambartolomeiCMisirR, and others. 2019. Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls. Mol Psychiatry24(11):1685–95.
33.
HenriquesTScruggsBSInouyeMOMuseGWWilliamsLHBurkholderAB, and others. 2018. Widespread transcriptional pausing and elongation control at enhancers. Genes Dev32(1):26–41.
34.
HewardJARouxBTLindsayMA. 2015. Divergent signalling pathways regulate lipopolysaccharide-induced eRNA expression in human monocytic THP1 cells. FEBS Lett589(3):396–406.
35.
HoYElefantFLiebhaberSACookeNE. 2006. Locus control region transcription plays an active role in long-range gene activation. Mol Cell23(3):365–75.
36.
HodgesAStrandADAragakiAKKuhnASengstagTHughesG, and others. 2006. Regional and cellular gene expression changes in human Huntington’s disease brain. Hum Mol Genet15(6):965–77.
37.
HsiehCLFeiTChenYLiTGaoYWangX, and others. 2014. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation. Proc Natl Acad Sci U S A111(20):7319–24.
38.
HuangZLiangNGoniSDamdimopoulosAWangCBallaireR, and others. 2021. The corepressors GPS2 and SMRT control enhancer and silencer remodeling via eRNA transcription during inflammatory activation of macrophages. Mol Cell81(5):953–968.e9.
39.
KaikkonenMUSpannNJHeinzSRomanoskiCEAllisonKAStenderJD, and others. 2013. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell51(3):310–25.
40.
KimSHIn ChoiHChoiMRAnGYBinasBJungKH, and others. 2020. Epigenetic regulation of IFITM1 expression in lipopolysaccharide-stimulated human mesenchymal stromal cells. Stem Cell Res Ther11(1):16.
41.
KimTKHembergMGrayJMCostaAMBearDMWuJ, and others. 2010. Widespread transcription at neuronal activity-regulated enhancers. Nature465(7295):182–7.
KimYWLeeSYunJKimA.2015. Chromatin looping and eRNA transcription precede the transcriptional activation of gene in the beta-globin locus. Biosci Rep35(2):e00179.
44.
KochFFenouilRGutMCauchyPAlbertTKZacarias-CabezaJ, and others. 2011. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat Struct Mol Biol18(8):956–63.
45.
KoppFMendellJT. 2018. Functional classification and experimental dissection of long noncoding RNAs. Cell172(3):393–407.
LaiFGardiniAZhangAShiekhattarR.2015. Integrator mediates the biogenesis of enhancer RNAs. Nature525(7569):399–403.
48.
LaiFOromUACesaroniMBeringerMTaatjesDJBlobelGA, and others. 2013. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature494(7438):497–501.
49.
LaiFShiekhattarR.2014. Enhancer RNAs: the new molecules of transcription. Curr Opin Genet Dev25:38–42.
50.
LamMTChoHLeschHPGosselinDHeinzSTanaka-OishiY, and others. 2013. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature498(7455):511–5.
51.
Le GrasSKeimeCAnthonyALotzCDe LongprezLBrouilletE, and others. 2017. Altered enhancer transcription underlies Huntington’s disease striatal transcriptional signature. Sci Rep7:42875.
52.
LeeJHXiongFLiW.2020. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential. RNA Biol17(11):1550–9.
LiWNotaniDMaQTanasaBNunezEChenAY, and others. 2013. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature498(7455):516–20.
55.
LiWNotaniDRosenfeldMG. 2016. Enhancers as non-coding RNA transcription units: recent insights and future perspectives. Nat Rev Genet17(4):207–23.
56.
LiangJZhouHGerdtCTanMColsonTKayeKM, and others. 2016. Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation. Proc Natl Acad Sci U S A113(49):14121–6.
57.
LinYCBennerCManssonRHeinzSMiyazakiKMiyazakiM, and others. 2012. Global changes in the nuclear positioning of genes and intra- and interdomain genomic interactions that orchestrate B cell fate. Nat Immunol13(12):1196–204.
58.
LingJAinolLZhangLYuXPiWTuanD.2004. HS2 enhancer function is blocked by a transcriptional terminator inserted between the enhancer and the promoter. J Biol Chem279(49):51704–13.
59.
MahLSzabuniewiczCFioccoAJ. 2016. Can anxiety damage the brain?Curr Opin Psychiatry29(1):56–63.
60.
MahatDBKwakHBoothGTJonkersIHDankoCGPatelRK, and others. 2016. Base-pair-resolution genome-wide mapping of active RNA polymerases using precision nuclear run-on (PRO-seq). Nat Protoc11(8):1455–76.
61.
MeloCADrostJWijchersPJvan de WerkenHde WitEOude VrielinkJA, and others. 2013. ERNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell49(3):524–35.
62.
MousaviKZareHDell’orsoSGrontvedLGutierrez-CruzGDerfoulA, and others. 2013. ERNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol Cell51(5):606–17.
63.
NatoliGAndrauJC. 2012. Noncoding transcription at enhancers: general principles and functional models. Annu Rev Genet46:1–19.
64.
PandeySCSakharkarAJTangLZhangH.2015. Potential role of adolescent alcohol exposure-induced amygdaloid histone modifications in anxiety and alcohol intake during adulthood. Neurobiol Dis82:607–19.
65.
ParalkarVRTabordaCCHuangPYaoYKossenkovAVPrasadR, and others. 2016. Unlinking an lncRNA from its associated cis element. Mol Cell62(1):104–10.
66.
PetrijFGilesRHDauwerseHGSarisJJHennekamRCMasunoM, and others. 1995. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature376(6538):348–51.
67.
PnueliLRudnizkySYosefzonYMelamedP.2015. RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin α-subunit gene. Proc Natl Acad Sci U S A112(14):4369–74.
68.
Rada-IglesiasABajpaiRSwigutTBrugmannSAFlynnRAWysockaJ.2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature470(7333):279–83.
69.
RahnamounHLuHDuttkeSHBennerCGlassCKLauberthSM. 2017. Mutant p53 shapes the enhancer landscape of cancer cells in response to chronic immune signaling. Nat Commun8(1):754.
70.
RoelfsemaJHWhiteSJAriyürekYBartholdiDNiedristDPapadiaF, and others. 2005. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet76(4):572–80.
71.
Romero-ZerboYDecaraJel BekayRSanchez-SalidoLDel Arco-HerreraIde FonsecaFR, and others. 2009. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome. J Pineal Res46(2):224–34.
72.
RouxBTLindsayMAHewardJA. 2017. Knockdown of nuclear-located enhancer RNAs and long ncRNAs using locked nucleic acid GapmeRs. Methods Mol Biol1468:11–8.
73.
SanyalALajoieBRJainGDekkerJ.2012. The long-range interaction landscape of gene promoters. Nature489(7414):109–13.
74.
SartorelliVLauberthSM. 2020. Enhancer RNAs are an important regulatory layer of the epigenome. Nat Struct Mol Biol27(6):521–8.
75.
SchaukowitchKJooJYLiuXWattsJKMartinezCKimTK. 2014. Enhancer RNA facilitates NELF release from immediate early genes. Mol Cell56(1):29–42.
76.
Schizophrenia Working Group of the Psychiatric Genomics Consortium. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature511(7510):421–7.
77.
SigovaAAAbrahamBJJiXMolinieBHannettNMGuoYE, and others. 2015. Transcription factor trapping by RNA in gene regulatory elements. Science350(6263):978–81.
78.
SunDGoldALSwansonCAHaswellCCBrownVMStjepanovicD, and others. 2020. Threat-induced anxiety during goal pursuit disrupts amygdala-prefrontal cortex connectivity in posttraumatic stress disorder. Transl Psychiatry10(1):61.
79.
SunJHZhouLEmersonDJPhyoSATitusKRGongW, and others. 2018. Disease-associated short tandem repeats co-localize with chromatin domain boundaries. Cell175(1):224–238.e15.
80.
TuvikeneJEsvaldEERahniAUustaluKZhuravskayaAAvarlaidA, and others. 2021. Intronic enhancer region governs transcript-specific Bdnf expression in rodent neurons. Elife10:e65161.
81.
UlitskyIBartelDP. 2013. LincRNAs: genomics, evolution, and mechanisms. Cell154(1):26–46.
82.
WangDGarcia-BassetsIBennerCLiWSuXZhouY, and others. 2011. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature474(7351):390–4.
83.
WeissLAArkingDEDalyMJChakravartiA.2009. A genome-wide linkage and association scan reveals novel loci for autism. Nature461(7265):802–8.
84.
WyseATSSanchesEFDos SantosTMSiebertCKollingJNettoCA. 2020. Chronic mild hyperhomocysteinemia induces anxiety-like symptoms, aversive memory deficits and hippocampus atrophy in adult rats: new insights into physiopathological mechanisms. Brain Res1728:146592.
85.
XiongLKangRDingRKangWZhangYLiuW, and others. 2018. Genome-wide identification and characterization of enhancers across 10 human tissues. Int J Biol Sci14(10):1321–32.
86.
XuNLiuBLianCDoychevaDMFuZLiuY, and others. 2018. Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma. Cell Death Dis9(12):1139.
87.
YangYSuZSongXLiangBZengFChangX, and others. 2016. Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster. Sci Rep6:20961.
88.
YaoPLinPGokoolparsadhAAssarehAThangMWVoineaguI.2015. Coexpression networks identify brain region-specific enhancer RNAs in the human brain. Nat Neurosci18(8):1168–74.
89.
ZhangXPangPJiangMCaoQLiHXuY, and others. 2020a. ERNAs and superenhancer lncRNAs are functional in human prostate cancer. Dis Markers2020:8847986.
90.
ZhangYQianMTangFHuangQWangWLiY, and others. 2020b. Identification and analysis of p53-regulated enhancers in hepatic carcinoma. Front Bioeng Biotechnol8:668.
91.
ZhangZHongWRuanHJingYLiSLiuY, and others. 2021. HeRA: an atlas of enhancer RNAs across human tissues. Nucleic Acids Res49(D1):D932–D938.
92.
ZhangZLeeJHRuanHYeYKrakowiakJHuQ, and others. 2019. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer. Nat Commun10(1):4562.
93.
ZhaoJZhaoYWangLZhangJKarnesRJKohliM, and others. 2016. Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer. Oncotarget7(25):38551–65.
